SCHEMBL29293547

SCHEMBL29293547

C=Nc1cc(Cl)ccc1CCN1CCCCC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 1/20 0.43
▸ MAOB P27338 1/20 0.43
▸ TMEM97 Q5BJF2 4/20 0.42
▸ SIGMAR1 Q99720 2/20 0.41
▸ L3MBTL3 Q96JM7 2/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.40
▸ TP53BP1 Q12888 1/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ HRH3 Q9Y5N1 3/20 0.40
▸ POLB P06746 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ CHRM2 P08172 1/20 0.40
▸ ADRA2C P18825 1/20 0.40
▸ SLC6A2 P23975 1/20 0.40
▸ SLC6A4 P31645 1/20 0.40
▸ HRH1 P35367 1/20 0.40
▸ SLC6A3 Q01959 1/20 0.40
▸ KCNH2 Q12809 1/20 0.40
▸ CACNA1C Q13936 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29293271 0.73 KCNH2 (0.36) KDM4EALDH1A1POLBSLC6A2SLC6A4
SCHEMBL29293219 0.69 TAAR1 (0.49) ADRA2CSLC6A4
SCHEMBL27689434 0.69 HRH3 (0.71) TMEM97SIGMAR1L3MBTL3L3MBTL1KDM4E
SCHEMBL30596611 0.66 KDM4E (0.71) SIGMAR1KDM4EALDH1A1POLBTDP1
SCHEMBL28001277 0.66 KCNH2 (0.79) SIGMAR1L3MBTL1KDM4EALDH1A1HRH3
SCHEMBL3863293 0.66 L3MBTL3 (0.53) MAOAMAOBSIGMAR1L3MBTL3L3MBTL1
SCHEMBL7304319 0.65 MAOA (0.60) MAOAMAOBSIGMAR1L3MBTL3L3MBTL1
SCHEMBL26015376 0.65 SLC6A4 (0.49) TMEM97SIGMAR1HRH3CHRM2ADRA2C
SCHEMBL24508364 0.64 KDM4E (0.73) SIGMAR1KDM4EALDH1A1POLBTDP1
SCHEMBL26508384 0.64 HTR2A (0.65) SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3735411-B1 1,3,4,5-TETRAHYDRO-2H-PYRIDO[4,3-B]INDOLE DERIVATIVES FOR THE TREATMENT, ALLEVIATION OR PREVENTION OF DISORDERS ASSOCIATED WITH TAU AGGREGATES LIKE ALZHEIMER`S DISEASE AC IMMUNE SA (CH) 2024-07-10 — — EP disclosed
Send feedback